BIOTECH INSIGHTS
Big Pharma Dives Into CBD: Who Could Be Next?
As many of you know, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) agreed in early February to acquire GW Pharmaceuticals plc (NASDAQ: GWPH) for a total...
BIOTECH NEWS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises...
Oakville, Ontario--(Newsfile Corp. - March 2, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused...
Big Pharma Dives Into CBD: Who Could Be Next?
As many of you know, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) agreed in early February to acquire GW Pharmaceuticals plc (NASDAQ: GWPH) for a total...
Advertisement
CEO INTERVIEWS
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
In this episode of Biotech Stocktrader, we are joined by Dr. Nader Pourhassan, President and CEO of CytoDyn, a biotechnology company developing innovative treatments...
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
In this episode of BiotechStocktrader we are joined by Dr. Carl Schwartz, CEO of Precision Therapeutics, ticker AIPT.
About Precision Therapeutics Inc.
Precision Therapeutics (AIPT)...
